chembio draw 3d (Chembio Diagnostics)
86
Structured Review
Chembio Diagnostics
chembio draw 3d
Chembio Draw 3d, supplied by Chembio Diagnostics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/3d+drawing/3d+chembio+draw/pm40818781-97-9-9
Average 86 stars, based on 1 article reviews
Chembio Draw 3d, supplied by Chembio Diagnostics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/3d+drawing/3d+chembio+draw/pm40818781-97-9-9
Average 86 stars, based on 1 article reviews
chembio draw 3d - by Bioz Stars,
2026-11
86/100 stars
Images
Related Articles
Construct:Article Title: Lonicerin targets EZH2 to alleviate ulcerative colitis by autophagy-mediated NLRP3 inflammasome inactivation Article Snippet: .. The three-dimensional structure of lonicerin was constructed using Article Title: Enhancement of MAVS UFMylation and inhibition of lysosomal degradation of MAVS aggregates: New findings on broad-spectrum antiviral mechanism of Anemoside B4. Article Snippet: RNA viruses have evolved various strategies to bypass the mitochondrial antiviral-signaling protein (MAVS) pathway, effectively sidestepping the host’s innate immunity.. Therefore, searching for MAVS signalosome regulators is crucial for the development of antiviral drugs.. Here, we found RNA viral-drived MAVS lysosomal trafficking was inhibited by Anemoside B4 (B4), a triterpenoid saponin from the herbal medicine Pulsatilla chinensis (Bunge) Regel., has significant antiviral activity. Article Title: Design, synthesis and biological evaluation of tasiamide B derivatives as BACE1 inhibitors. Article Snippet: Article history: Received 17 January 2015 Revised 10 March 2015 Accepted 11 March 2015 Available online 20 March 2015 Article Title: Discovery of N-(2-phenyl-1H-benzo[d]imidazol-5-yl)quinolin-4-amine derivatives as novel VEGFR-2 kinase inhibitors. Article Snippet: Inhibition of the VEGF signaling pathway has become a valuable approach in the treatment of cancers.. In this work, a series of N-(2-phenyl-1H-benzo[d]imidazol-5-yl)quinolin-4-amine derivatives were designed and identified as potent inhibitors of VEGFR-2 (KDR) kinase.. These compounds with quinoline scaffold and benzimidazole moiety were synthesized and their biological activities against VEGFR-2 and two human cancer cell lines were evaluated. Software:Article Title: Lonicerin targets EZH2 to alleviate ulcerative colitis by autophagy-mediated NLRP3 inflammasome inactivation Article Snippet: .. The three-dimensional structure of lonicerin was constructed using Article Title: Enhancement of MAVS UFMylation and inhibition of lysosomal degradation of MAVS aggregates: New findings on broad-spectrum antiviral mechanism of Anemoside B4. Article Snippet: RNA viruses have evolved various strategies to bypass the mitochondrial antiviral-signaling protein (MAVS) pathway, effectively sidestepping the host’s innate immunity.. Therefore, searching for MAVS signalosome regulators is crucial for the development of antiviral drugs.. Here, we found RNA viral-drived MAVS lysosomal trafficking was inhibited by Anemoside B4 (B4), a triterpenoid saponin from the herbal medicine Pulsatilla chinensis (Bunge) Regel., has significant antiviral activity. Article Title: Design, synthesis and biological evaluation of tasiamide B derivatives as BACE1 inhibitors. Article Snippet: Article history: Received 17 January 2015 Revised 10 March 2015 Accepted 11 March 2015 Available online 20 March 2015 Article Title: Discovery of N-(2-phenyl-1H-benzo[d]imidazol-5-yl)quinolin-4-amine derivatives as novel VEGFR-2 kinase inhibitors. Article Snippet: Inhibition of the VEGF signaling pathway has become a valuable approach in the treatment of cancers.. In this work, a series of N-(2-phenyl-1H-benzo[d]imidazol-5-yl)quinolin-4-amine derivatives were designed and identified as potent inhibitors of VEGFR-2 (KDR) kinase.. These compounds with quinoline scaffold and benzimidazole moiety were synthesized and their biological activities against VEGFR-2 and two human cancer cell lines were evaluated. other:Article Title: Design, synthesis and biological evaluation of N-phenylquinazolin-4-amine hybrids as dual inhibitors of VEGFR-2 and HDAC. Article Snippet: A single agent that simultaneously inhibits multiple targets may offer greater therapeutic benefits in cancer than single-acting agents through interference with multiple pathways and potential synergistic action.. In this work, a series of hybrids bearing N-phenylquinazolin-4-amine and hydroxamic acid moieties were designed and identified as dual VEGFR-2/HDAC inhibitors.. Compound 6fd exhibited the most potent inhibitory activity against HDAC with IC50 of 2.2 nM and strong inhibitory effect against VEGFR-2 with IC50 of 74 nM. Article Title: Discovery of Potent c-MET Inhibitors with New Scaffold Having Different Quinazoline, Pyridine and Tetrahydro-Pyridothienopyrimidine Headgroups Article Snippet: The three-dimensional structure of all compounds was constructed using Article Title: Therapeutic targeting of BAP1/ASXL3 sub-complex in ASCL1-dependent small cell lung cancer Article Snippet: The three-dimensional structures of the compounds iBAP and iBAP-II were constructed using Article Title: Hybrids from 4-anilinoquinazoline and hydroxamic acid as dual inhibitors of vascular endothelial growth factor receptor-2 and histone deacetylase. Article Snippet: Accepted Manuscript Hybrids from 4-anilinoquinazoline and hydroxamic acid as dual inhibitors of vascular endothelial growth factor receptor-2 and histone deacetylase Fan-Wei Peng, Ting-Ting Wu, Zi-Wei Zeng, Jia-Yu Xue, Lei Shi PII: S0960-894X(15)30114-1 DOI: http://dx.doi.org/10.1016/j.bmcl.2015.10.006 Reference: BMCL 23162 To appear in: Bioorganic & Medicinal Chemistry Letters Received Date: 1 September 2015 Revised Date: 29 September 2015 Accepted Date: 3 October 2015 Please cite this article as: Peng, F-W., Wu, T-T., Zeng, Z-W., Xue, J-Y., Shi, L., Hybrids from 4-anilinoquinazoline and hydroxamic acid as dual inhibitors of vascular endothelial growth factor receptor-2 and histone deacetylase, Bioorganic & Medicinal Chemistry Letters (2015), doi: http://dx.doi.org/10.1016/j.bmcl.2015.10.006 This is a PDF file of an unedited manuscript that has been accepted for publication.. As a service to our customers we are providing this early version of the manuscript.. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. |
